Circulating Tumor Reactive KIR+CD8+ T cells Suppress Anti-Tumor Immunity in Patients with Melanoma.
Hafler D, Lu B, Lucca L, Lewis W, Wang J, Nogeuira C, Heer S, Axisa PP, Buitrago-Pocasangre N, Pham G, Kojima M, Wei W, Aizenbud L, Bacchiocchi A, Zhang L, Walewski J, Chiang V, Olino K, Clune J, Halaban R, Kluger Y, Coyle A, Kisielow J, Obermair FJ, Kluger H.
Hafler D, et al. Among authors: olino k.
Res Sq [Preprint]. 2024 Feb 28:rs.3.rs-3956671. doi: 10.21203/rs.3.rs-3956671/v1.
Res Sq. 2024.
PMID: 38464315
Free PMC article.
Preprint.